Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Identification of natural compounds with antiviral activities against SARS-associated coronavirus
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Identification of natural compounds with antiviral activities against SARS-associated coronavirus
Creator
Wang, Hui
Wang, Lin
Chen, Cong
Yu, Jun
Tan, Xuehai
Zhang, Xiang
Li, Shi-You
Guo, Hai-Yan
Hua, Shi-Neng
Li, Rong-Song
Xiao, Pei-Gen
Zhang, Hai-Qing
Source
Elsevier; Medline; PMC
abstract
Abstract More than 200 Chinese medicinal herb extracts were screened for antiviral activities against Severe Acute Respiratory Syndrome-associated coronavirus (SARS-CoV) using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt (MTS) assay for virus-induced cytopathic effect (CPE). Four of these extracts showed moderate to potent antiviral activities against SARS-CoV with 50% effective concentration (EC50) ranging from 2.4±0.2 to 88.2±7.7μg/ml. Out of the four, Lycoris radiata was most potent. To identify the active component, L. radiata extract was subjected to further fractionation, purification, and CPE/MTS assays. This process led to the identification of a single substance lycorine as an anti-SARS-CoV component with an EC50 value of 15.7±1.2nM. This compound has a CC50 value of 14980.0±912.0nM in cytotoxicity assay and a selective index (SI) greater than 900. The results suggested that four herbal extracts and the compound lycorine are candidates for the development of new anti-SARS-CoV drugs in the treatment of SARS.
has issue date
2005-07-31
(
xsd:dateTime
)
bibo:doi
10.1016/j.antiviral.2005.02.007
bibo:pmid
15885816
has license
els-covid
sha1sum (hex)
a7cb77c6d80a536ff5c0ac3b94142e9c7014b5e6
schema:url
https://doi.org/10.1016/j.antiviral.2005.02.007
resource representing a document's title
Identification of natural compounds with antiviral activities against SARS-associated coronavirus
has PubMed Central identifier
PMC7114104
has PubMed identifier
15885816
schema:publication
Antiviral Research
resource representing a document's body
covid:a7cb77c6d80a536ff5c0ac3b94142e9c7014b5e6#body_text
is
schema:about
of
named entity 'assay'
named entity 'CPE'
named entity 'herbal'
named entity 'screened'
named entity 'selective'
covid:arg/a7cb77c6d80a536ff5c0ac3b94142e9c7014b5e6
named entity 'ACUTE'
named entity 'CPE'
named entity 'ACTIVITIES'
named entity 'CYTOPATHIC EFFECT'
named entity '1.2'
named entity 'GREATER THAN'
named entity '2.4'
named entity 'SINGLE'
named entity '200'
named entity 'DRUGS'
named entity 'INDUCED'
named entity 'TETRAZOLIUM'
named entity 'COMPONENT'
named entity 'SALT'
named entity 'CYTOTOXICITY ASSAY'
named entity 'TREATMENT'
named entity 'SUBSTANCE'
named entity '283'
named entity 'PROCESS'
named entity '2C5'
named entity 'ACTIVE'
named entity 'TO IDENTIFY'
named entity 'DEVELOPMENT'
named entity 'LYCORIS RADIATA'
named entity 'USING'
named entity '912'
named entity 'SARS'
named entity 'RESULTS'
named entity 'SARS-COV'
named entity 'ANTIVIRAL'
named entity 'VALUE'
named entity 'IDENTIFICATION'
named entity 'SARS-ASSOCIATED CORONAVIRUS'
named entity 'NATURAL'
named entity 'CORONAVIRUS'
named entity 'INNER'
named entity 'RADIATA'
named entity 'ASSAY'
named entity 'SELECTIVE'
named entity '50%'
named entity 'PURIFICATION'
named entity 'VIRUS'
named entity 'FRACTIONATION'
named entity 'CONCENTRATION'
named entity 'INDEX'
named entity 'SEVERE'
named entity 'EXTRACT'
named entity 'EFFECTIVE'
named entity 'LED'
named entity 'MORE THAN'
named entity 'MEDICINAL HERB'
named entity 'CHINESE'
named entity 'ANTIVIRAL'
named entity 'IDENTIFICATION'
named entity 'EXTRACTS'
named entity '900'
named entity 'COMPOUND'
named entity 'NEW'
named entity '7.7'
named entity 'RESPIRATORY'
named entity 'MODERATE'
named entity 'THESE'
named entity 'HERBAL'
named entity 'LYCORINE'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 5
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software